SCHEMBL8987140

SCHEMBL8987140

O=c1cc(-c2ccccc2)cc(C2CC2)[nH]1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
YTHDF2 Q9Y5A9 2/20 0.52
YTHDF3 Q7Z739 1/20 0.52
YTHDF1 Q9BYJ9 1/20 0.52
NOTUM Q6P988 1/20 0.43
HTT P42858 2/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TAS2R38 P59533 1/20 0.40
XDH P47989 2/20 0.39
TNKS2 Q9H2K2 1/20 0.39
PDE2A O00408 1/20 0.39
CDC7 O00311 1/20 0.38
DBF4 Q9UBU7 1/20 0.38
HSD17B10 Q99714 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
PLAT P00750 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9522290 1.00 YTHDF2 (0.52) YTHDF2YTHDF3YTHDF1NOTUMHTT
SCHEMBL16300069 0.81 YTHDF3 (0.35) YTHDF2YTHDF3YTHDF1PDE2ACDC7
SCHEMBL1348693 0.79 YTHDF3 (0.45) YTHDF2YTHDF3YTHDF1HPGDPDE2A
SCHEMBL6756097 0.71 TAS2R38 (0.60) NOTUMHTTHPGDMAPK1SMN1; SMN2
SCHEMBL19583295 0.69 YTHDF2 (0.59) YTHDF2YTHDF3YTHDF1HPGDSMN1; SMN2
SCHEMBL29316666 0.69 YTHDF2 (0.59) YTHDF2YTHDF3YTHDF1HPGDSMN1; SMN2
SCHEMBL28197130 0.69 YTHDF2 (0.59) YTHDF2YTHDF3YTHDF1HPGDSMN1; SMN2
SCHEMBL11374087 0.69 HTT (0.50) NOTUMHTTHPGDMAPK1SMN1; SMN2
SCHEMBL2331587 0.69 TNKS2 (0.51) NOTUMHTTHPGDMAPK1SMN1; SMN2
SCHEMBL16382638 0.69 HTT (0.50) NOTUMHTTHPGDMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5492915-A ANTIINFLAMMATORY AGENTS RHONE-POULENC RORER S.A. (FR) 1996-02-20 US disclosed
US-5366982-A Antiinflammatory agents or antihistamines RHONE-POULENC RORER S.A. (FR) 1994-11-22 US disclosed
EP-0540604-A1 SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B 4? ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS Aventis Pharma S.A. (FR) 1993-05-12 EP disclosed
WO-1992001675-A2 SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B4 ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS RHONE-POULENC RORER S.A. (FR) 1992-02-06 WO disclosed